John Dwyer Appointed Chairman of Xeinadin
Professional services group Xeinadin has appointed John Dwyer as its new chairman, effective immediately. Dwyer succeeds Alastair Marsh, who is stepping down after six years on the board and serving as independent non-executive chairman since 2021. During his tenure, Marsh oversaw significant growth for Xeinadin, including a minority stake sale to Exponent in 2022. Dwyer joined Xeinadin's board in 2022 and brings extensive experience from roles at PricewaterhouseCoopers and as part of Exponent’s investment team. CEO Derry Crowley praised Marsh for his guidance during the firm’s transformational period, while expressing confidence that Dwyer will continue to lead Xeinadin on its growth journey. The leadership change follows recent expansion efforts by Xeinadin, including an acquisition in Dublin earlier this year.
